vs

Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Zymeworks Inc. (ZYME). Click either name above to swap in a different company.

FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $27.6M, roughly 1.1× Zymeworks Inc.). FGI Industries Ltd. runs the higher net margin — -8.6% vs -71.0%, a 62.4% gap on every dollar of revenue. On growth, Zymeworks Inc. posted the faster year-over-year revenue change (72.6% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-31.8M).

FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.

Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company's molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital th...

FGI vs ZYME — Head-to-Head

Bigger by revenue
FGI
FGI
1.1× larger
FGI
$30.5M
$27.6M
ZYME
Growing faster (revenue YoY)
ZYME
ZYME
+87.0% gap
ZYME
72.6%
-14.4%
FGI
Higher net margin
FGI
FGI
62.4% more per $
FGI
-8.6%
-71.0%
ZYME
More free cash flow
FGI
FGI
$34.1M more FCF
FGI
$2.3M
$-31.8M
ZYME

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FGI
FGI
ZYME
ZYME
Revenue
$30.5M
$27.6M
Net Profit
$-2.6M
$-19.6M
Gross Margin
26.7%
Operating Margin
-2.2%
-80.1%
Net Margin
-8.6%
-71.0%
Revenue YoY
-14.4%
72.6%
Net Profit YoY
-553.1%
34.3%
EPS (diluted)
$-1.63
$-0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FGI
FGI
ZYME
ZYME
Q4 25
$30.5M
Q3 25
$35.8M
$27.6M
Q2 25
$31.0M
$48.7M
Q1 25
$33.2M
$27.1M
Q4 24
$35.6M
$31.0M
Q3 24
$36.1M
$16.0M
Q2 24
$29.4M
$19.2M
Q1 24
$30.8M
$10.0M
Net Profit
FGI
FGI
ZYME
ZYME
Q4 25
$-2.6M
Q3 25
$-1.7M
$-19.6M
Q2 25
$-1.2M
$2.3M
Q1 25
$-629.1K
$-22.6M
Q4 24
$-402.3K
$-23.5M
Q3 24
$-550.1K
$-29.9M
Q2 24
$163.6K
$-37.7M
Q1 24
$-412.2K
$-31.7M
Gross Margin
FGI
FGI
ZYME
ZYME
Q4 25
26.7%
Q3 25
26.5%
Q2 25
28.1%
Q1 25
26.8%
Q4 24
24.6%
Q3 24
25.8%
Q2 24
30.5%
Q1 24
27.4%
Operating Margin
FGI
FGI
ZYME
ZYME
Q4 25
-2.2%
Q3 25
1.0%
-80.1%
Q2 25
-2.7%
-1.4%
Q1 25
-3.9%
-94.5%
Q4 24
-3.5%
-71.6%
Q3 24
-0.2%
-213.8%
Q2 24
-1.5%
-222.9%
Q1 24
-1.0%
-376.9%
Net Margin
FGI
FGI
ZYME
ZYME
Q4 25
-8.6%
Q3 25
-4.6%
-71.0%
Q2 25
-4.0%
4.8%
Q1 25
-1.9%
-83.5%
Q4 24
-1.1%
-75.8%
Q3 24
-1.5%
-186.6%
Q2 24
0.6%
-195.8%
Q1 24
-1.3%
-315.6%
EPS (diluted)
FGI
FGI
ZYME
ZYME
Q4 25
$-1.63
Q3 25
$-0.86
$-0.26
Q2 25
$-0.64
$0.03
Q1 25
$-0.07
$-0.30
Q4 24
$-0.38
$-0.32
Q3 24
$-0.29
$-0.39
Q2 24
$0.08
$-0.49
Q1 24
$-0.04
$-0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FGI
FGI
ZYME
ZYME
Cash + ST InvestmentsLiquidity on hand
$1.9M
$64.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$17.3M
$320.1M
Total Assets
$69.5M
$397.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FGI
FGI
ZYME
ZYME
Q4 25
$1.9M
Q3 25
$1.9M
$64.8M
Q2 25
$2.5M
$98.3M
Q1 25
$1.2M
$76.2M
Q4 24
$4.6M
$66.1M
Q3 24
$3.0M
$122.4M
Q2 24
$1.3M
$71.0M
Q1 24
$3.3M
$114.8M
Stockholders' Equity
FGI
FGI
ZYME
ZYME
Q4 25
$17.3M
Q3 25
$19.7M
$320.1M
Q2 25
$21.3M
$334.5M
Q1 25
$21.8M
$325.0M
Q4 24
$22.3M
$338.8M
Q3 24
$23.5M
$367.0M
Q2 24
$23.8M
$406.2M
Q1 24
$23.9M
$438.0M
Total Assets
FGI
FGI
ZYME
ZYME
Q4 25
$69.5M
Q3 25
$73.0M
$397.3M
Q2 25
$71.7M
$408.4M
Q1 25
$68.5M
$425.5M
Q4 24
$75.5M
$463.1M
Q3 24
$74.7M
$487.2M
Q2 24
$69.9M
$515.6M
Q1 24
$68.6M
$553.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FGI
FGI
ZYME
ZYME
Operating Cash FlowLast quarter
$2.3M
$-31.4M
Free Cash FlowOCF − Capex
$2.3M
$-31.8M
FCF MarginFCF / Revenue
7.5%
-115.2%
Capex IntensityCapex / Revenue
0.2%
1.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-212.5K
$-65.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FGI
FGI
ZYME
ZYME
Q4 25
$2.3M
Q3 25
$-1.9M
$-31.4M
Q2 25
$7.6M
$12.1M
Q1 25
$-7.4M
$-3.4M
Q4 24
$617.4K
$-41.5M
Q3 24
$-915.0K
$-5.9M
Q2 24
$862.1K
$-25.0M
Q1 24
$-8.0M
$-37.7M
Free Cash Flow
FGI
FGI
ZYME
ZYME
Q4 25
$2.3M
Q3 25
$-2.1M
$-31.8M
Q2 25
$7.4M
$11.6M
Q1 25
$-7.7M
$-3.4M
Q4 24
$-214.1K
$-41.8M
Q3 24
$-1.1M
$-6.8M
Q2 24
$281.5K
$-25.6M
Q1 24
$-8.6M
$-37.9M
FCF Margin
FGI
FGI
ZYME
ZYME
Q4 25
7.5%
Q3 25
-5.9%
-115.2%
Q2 25
23.8%
23.7%
Q1 25
-23.3%
-12.6%
Q4 24
-0.6%
-134.8%
Q3 24
-3.0%
-42.4%
Q2 24
1.0%
-133.0%
Q1 24
-28.0%
-377.5%
Capex Intensity
FGI
FGI
ZYME
ZYME
Q4 25
0.2%
Q3 25
0.7%
1.5%
Q2 25
0.7%
1.1%
Q1 25
1.1%
0.1%
Q4 24
2.3%
1.0%
Q3 24
0.5%
5.6%
Q2 24
2.0%
3.1%
Q1 24
2.0%
1.8%
Cash Conversion
FGI
FGI
ZYME
ZYME
Q4 25
Q3 25
Q2 25
5.21×
Q1 25
Q4 24
Q3 24
Q2 24
5.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FGI
FGI

Sanitaryware$19.1M63%
Shower System$5.8M19%
Kitchen And Bath Other$3.3M11%
Bath Furniture Products$2.3M7%

ZYME
ZYME

Segment breakdown not available.

Related Comparisons